Viking Therapeutics (VKTX) Non-Current Assets (2014 - 2026)
Viking Therapeutics (VKTX) recorded Non-Current Assets of $4.33 million in Q2 2026, up 419.7% from $834,000 a year earlier.
Powered by 
Analysis
Viking Therapeutics (VKTX) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Viking Therapeutics reported Non-Current Assets of $131,000, down 88.1% from FY2024.
- Annual Non-Current Assets has declined for three straight years, with a five-year compound annual growth rate of -19.9% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $1.11 million in FY2024 (-12.6%), $1.27 million in FY2023 (-15.0%), $1.49 million in FY2022 and $134,000 in FY2021 (-66.3%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets in data going back to Q4 2014.
- On a year-over-year basis, Non-Current Assets rose in 1 of the last eight quarters, with growth averaging 15.9%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 798.9% in Q2 2022, against a decline of 96.6% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $33,000 (Q1 2026), $131,000 (Q4 2025) and $712,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Viking Therapeutics | 3.10 Bn | 576.60 Mn | - | 4.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.33 Mn |
| Mar 31, 2026 | 33,000.00 |
| Dec 31, 2025 | 131,000.00 |
| Sep 30, 2025 | 712,000.00 |
| Jun 30, 2025 | 834,000.00 |
| Mar 31, 2025 | 970,000.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.65 Mn |
| Mar 31, 2022 | 1.73 Mn |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 189,000.00 |
API Access
Viking Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();